North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,306 Jan 1 – Oct 26, 2026
- Disclosed funding
- $251.5B 1913 disclosed amounts
- Median round
- $23.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TorqCompany profile Empowers enterprises to instantly and precisely detect and respond to security events at scale Empowers enterprises to instantly and precisely detect and respond to security events at scale | $140M | Series DSeries C+ | Cybersecurity | United States | Investors | |
| KT Develops inhaled therapies for severe respiratory diseases | $103M | Series B | Biotech | United States | Investors | |
| VS Develops a ureteroscopic system for complete kidney stone clearance | $30M | Series A | Healthtech | United States | Investors | |
| R Provides enterprise-grade infrastructure for stablecoin-powered payments | $250M | Series CSeries C+ | Fintech | United States | Investors | |
| MM Major Medical DevicesCompany profile Develops innovative vascular intervention solutions for abdominal aortic aneurysms Develops innovative vascular intervention solutions for abdominal aortic aneurysms | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| B BradoCompany profile Provides Conversational Engagement Platform for patient navigation and engagement Provides Conversational Engagement Platform for patient navigation and engagement | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
 MEDIPOSTCompany profile MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. MEDIPOST develops stem-cell therapies derived from donated umbilical cord blood. | $140M | Undisclosed | Biotech | United States | Investors | |
| CI Provides AI-native, full-stack insurance for startups | $108M | Series A | Fintech | United States | Investors | |
| H Builds highly automated factories producing defense and aerospace systems | Undisclosed | Undisclosed | Industrial tech | United States | Investors | |
 AirNexis TherapeuticsCompany profile AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. | $200M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Databuddy Analytics
133rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
70rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.